Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2008-5115

2. Registrant Information.

Registrant Reference Number: 2008-IR-10

Registrant Name (Full Legal Name no abbreviations): E. I. du Pont Canada Company

Address: P.O. box 2300, Streetsville

City: Mississauga

Prov / State: ON

Country: Canada

Postal Code: L5M 2J4

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No. 19696      PMRA Submission No.       EPA Registration No.

Product Name: Linuron Flake Technical

• Active Ingredient(s)
  • LINURON

7. b) Type of formulation.

Dry Flowable (water dispersible granules)

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title Product Registration Manager

Date 23-JUL-08

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

Increased health or environmental risk

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

Recently E.I. duPont de Nemours and Company using non-GLD screening methodology to screen samples of our current sources of linuron technical. As part of this preliminary screening DuPont noticed existing linuron impurities at levels that when tested with fully validated methodology, may be at high enough levels to trigger addition to our Product Specification Form. None of the impurities were considered of toxicological significance at the levels observed.

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here

Please see attachment for full details.